Published in J Control Release on March 01, 2000
Utility of physiologically based absorption modeling in implementing Quality by Design in drug development. AAPS J (2011) 1.10
Influence of drug release properties of conventional solid dosage forms on the systemic exposure of highly soluble drugs. AAPS PharmSci (2001) 1.06
Modeling kinetics of subcellular disposition of chemicals. Chem Rev (2009) 0.96
Mechanistic approaches to predicting oral drug absorption. AAPS J (2009) 0.90
Drug absorption modeling as a tool to define the strategy in clinical formulation development. AAPS J (2008) 0.87
In vitro-in vivo correlation for gliclazide immediate-release tablets based on mechanistic absorption simulation. AAPS PharmSciTech (2010) 0.81
Incorporation of ABCB1-mediated transport into a physiologically-based pharmacokinetic model of docetaxel in mice. J Pharmacokinet Pharmacodyn (2013) 0.79
Comparative QSAR studies on PAMPA/modified PAMPA for high throughput profiling of drug absorption potential with respect to Caco-2 cells and human intestinal absorption. J Comput Aided Mol Des (2007) 0.78
WebPK, a web-based tool for custom pharmacokinetic simulation. Conf Proc IEEE Eng Med Biol Soc (2010) 0.75
Relationship of quantitative structure and pharmacokinetics in fluoroquinolone antibacterials. World J Gastroenterol (2007) 0.75
Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide. Proc Natl Acad Sci U S A (2005) 1.60
Improving the ocular to systemic ratio of topical timolol by varying the dosing time. Invest Ophthalmol Vis Sci (1991) 1.40
Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir. Biochem Biophys Res Commun (1998) 1.33
Estimating human oral fraction dose absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds. Pharm Res (1988) 1.15
Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line. J Pharmacol Exp Ther (1999) 1.12
Characterization of the unstirred water layer in Caco-2 cell monolayers using a novel diffusion apparatus. Pharm Res (1991) 1.03
Oral delivery of salmon calcitonin. Adv Drug Deliv Rev (2000) 1.03
Effects of calcium chelating agents on corneal permeability. Invest Ophthalmol Vis Sci (1985) 1.01
Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells. Pharm Res (1998) 0.99
Predicting fraction dose absorbed in humans using a macroscopic mass balance approach. Pharm Res (1991) 0.98
Evidence for diminished functional expression of intestinal transporters in Caco-2 cell monolayers at high passages. Pharm Res (1997) 0.97
Membrane permeability parameters for some amino acids and beta-lactam antibiotics: application of the boundary layer approach. J Theor Biol (1988) 0.95
Targeting the sodium-dependent multivitamin transporter (SMVT) for improving the oral absorption properties of a retro-inverso Tat nonapeptide. Pharm Res (2001) 0.91
Relationship of chemical structure to corneal penetration and influence of low-viscosity solution on ocular bioavailability. J Pharm Sci (1984) 0.90
siRNA--getting the message out. Eur J Pharm Sci (2006) 0.87
Targeted PEG-based bioconjugates enhance the cellular uptake and transport of a HIV-1 TAT nonapeptide. J Control Release (2001) 0.87
Influence of the microporous substratum and hydrodynamics on resistances to drug transport in cell culture systems: calculation of intrinsic transport parameters. J Pharm Sci (1997) 0.85
Development of a novel intestinal and vascular access port (IVAP) rabbit model to study regiospecific oral absorption pharmacokinetics. Comp Med (2001) 0.84
Comparison of the permeability characteristics of a human colonic epithelial (Caco-2) cell line to colon of rabbit, monkey, and dog intestine and human drug absorption. Pharm Res (1993) 0.84
Toxicodynamics of rigid polystyrene microparticles on pulmonary gas exchange in mice: implications for microemboli-based drug delivery systems. Toxicol Appl Pharmacol (2012) 0.83
Enhanced immunogenicity of a recombinant genital warts vaccine adjuvanted with monophosphoryl lipid A. Vaccine (1998) 0.81
An investigation of the intradermal route as an effective means of immunization for microparticulate vaccine delivery systems. Vaccine (2000) 0.81
Determining the absolute surface hydrophobicity of microparticulates using thin layer wicking. J Control Release (1999) 0.80
Analysis of intestinal perfusion data for highly permeable drugs using a numerical aqueous resistance--nonlinear regression method. Pharm Res (1996) 0.79
Improved longevity and functionality of a canine model providing portal vein and multi-site intestinal access. Comp Med (2000) 0.79
Permeability characteristics of various intestinal regions of rabbit, dog, and monkey. Pharm Res (1992) 0.79
Ocular delivery of pilocarpine from erodible matrices. J Pharm Sci (1984) 0.78
Characterization of the oral absorption of several aminopenicillins: determination of intrinsic membrane absorption parameters in the rat intestine in situ. Int J Pharm (1992) 0.78
Oral absorption of anti-aids nucleoside analogues: 3. Regional absorption and in vivo permeability of 2',3'-dideoxyinosine in an intestinal-vascular access port (IVAP) dog model. Biopharm Drug Dispos (1997) 0.78
Differentiation of gut and hepatic first-pass effect of drugs: 1. Studies of verapamil in ported dogs. Pharm Res (2001) 0.78
Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: in vitro permeability and in vivo oral absorption of salmon calcitonin (sCT). Pharm Res (1999) 0.78
Pharmacokinetic basis for nonadditivity of intraocular pressure lowering in timolol combinations. Invest Ophthalmol Vis Sci (1991) 0.78
Improving intestinal absorption of water-insoluble compounds: a membrane metabolism strategy. J Pharm Sci (1980) 0.78
Mechanism of dextran transport across rabbit intestinal tissue and a human colon cell-line (CACO-2). J Drug Target (1995) 0.78
Regional oral absorption, hepatic first-pass effect, and non-linear disposition of salmon calcitonin in beagle dogs. Eur J Pharm Biopharm (2000) 0.77
Characterization of the oral absorption of some beta-lactams: effect of the alpha-amino side chain group. J Pharm Sci (1993) 0.77
Prodrug and conjugate drug delivery strategies for improving HIV/AIDS therapy. J Drug Deliv Sci Technol (2009) 0.77
Pharmacokinetic studies in Tg.AC and FVB mice administered [14C] benzene either by oral gavage or intradermal injection. Toxicol Appl Pharmacol (2001) 0.76
Active efflux kinetics of etoposide from rabbit small intestine and colon. Biopharm Drug Dispos (2000) 0.76
Impact of regional intestinal pH modulation on absorption of peptide drugs: oral absorption studies of salmon calcitonin in beagle dogs. Pharm Res (1999) 0.76
Mass balance approaches for estimating the intestinal absorption and metabolism of peptides and analogues: theoretical development and applications. Pharm Res (1993) 0.76
Antiherpes simplex virus type 2 activity of the antimicrobial peptide subtilosin. J Appl Microbiol (2014) 0.75
Fed-state effects on zidovudine absorption. AIDS (1991) 0.75
Pharmacokinetics of benzene following an oral or intradermal dose in FVB and Tg.AC mice. Adv Exp Med Biol (2001) 0.75
An apparatus and method for the coating of solid particles. J Pharm Sci (1968) 0.75
Oral absorption of anti-acquired immune deficiency syndrome nucleoside analogues. 2. Carrier-mediated intestinal transport of stavudine in rat and rabbit preparations. J Pharm Sci (1996) 0.75
Optimization of autoclave cycles and selection of formulation for parenteral products, Part II: Effect of counter-ion on pH and stability of diatrizoic acid at autoclave temperatures. J Parenter Sci Technol (1984) 0.75
Adjuvancy enhancement of muramyl dipeptide by modulating its release from a physicochemically modified matrix of ovalbumin microspheres. I. In vitro characterization. J Control Release (2000) 0.75
Regional differences in intestinal spreading and pH recovery and the impact on salmon calcitonin absorption in dogs. Pharm Res (2000) 0.75
Optimization of autoclave cycles and selection of formulation for parenteral products, Part III: Effect of formulation variables on sporicidal kinetics. J Parenter Sci Technol (1984) 0.75
Optimization of autoclave cycles and selection of formulation for parenteral products, Part I: Identification of autoclave conditions by a nonisothermal approach. J Parenter Sci Technol (1984) 0.75
A new side-by-side diffusion cell for studying transport across epithelial cell monolayers. In Vitro Cell Dev Biol (1992) 0.75
Adjuvancy enhancement of muramyl dipeptide by modulating its release from a physicochemically modified matrix of ovalbumin microspheres. II. In vivo investigation. J Control Release (2000) 0.75
Oxibendazole, a new broad spectrum anthelmintic effective against gastrointestinal nematodes of domestic animals. Br Vet J (1973) 0.75